In this review, we discuss the molecular circadian clock as a regulator of MYC expression under normal homeostasis, how MYC itself can influence circadian rhythmicity of individual cells, and how this bidirectional regulation is potentially disrupted in cancer. The gene discussed is CLOCK; the disease is cancer.